Mangoceuticals, Inc.
MGRX- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001938046
No open-market purchases or sales by Mangoceuticals, Inc. insiders were filed in the last 90 days; 18 institutions reported holding it in 13F filings for Q2 2026, worth $455.6K in total; no superinvestor holds it.
13F holders, Q4 2025
Institutional positions in Mangoceuticals, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +7 vs. Q3 2025
- Shares held
- 2.54M
- +2.16M (+577.3%) vs. Q3 2025
- Total value
- $1.88M
- +$1.06M (+129.0%) vs. Q3 2025
- New holders
- 10
- 5 more added
- Sold out
- 3
- 1 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 18 | $455.6K |
| Q1 2026 | 18 | $297.6K |
| Q4 2025 | 18 | $1.88M |
| Q3 2025 | 11 | $820.1K |
| Q2 2025 | 10 | $444.2K |
| Q1 2025 | 8 | $146.9K |
| Q4 2024 | 9 | $220.9K |
| Q3 2024 | 13 | $319.7K |
| Q2 2024 | 6 | $147.7K |
| Q1 2024 | 8 | $72.0K |
| Q4 2023 | 5 | $34.9K |
| Q3 2023 | 9 | $135.8K |
| Q2 2023 | 5 | $166.4K |
| Q1 2023 | 1 | $5.32K |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding Mangoceuticals, Inc.; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 1,536,000 | $1.14M | 0.03% | +1,536,000 | New |
| Vanguard Group Inc | 489,532 | $362.3K | 0.00% | +297,528+155.0% | Added |
| Ikarian Capital, LLC | 138,146 | $102.2K | 0.01% | +138,146 | New |
| Geode Capital Management, LLC | 108,322 | $80.2K | 0.00% | +20,348+23.1% | Added |
| Jane Street Group, LLC | 47,503 | $35.2K | 0.00% | +47,503 | New |
| UBS Group AG | 46,167 | $34.2K | 0.00% | +46,164+1,538,800.0% | Added |
| Boothbay Fund Management, LLC | 38,441 | $28.4K | 0.00% | +38,441 | New |
| Northern Trust Corp | 37,579 | $27.8K | 0.00% | +18,622+98.2% | Added |
| Ackerman Capital Advisors, LLC | 34,500 | $25.5K | 0.01% | 00.0% | Unchanged |
| Virtu Financial LLC | 33,462 | $25.0K | 0.00% | +33,462 | New |
| Sunbelt Securities, Inc. | 12,000 | $8.88K | 0.00% | +5,000+71.4% | Added |
| Csenge Advisory Group | 10,000 | $7.40K | 0.00% | +10,000 | New |
| Advisor Group Holdings, Inc. | 2,885 | $2.13K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,002 | $741 | 0.00% | +1,002 | New |
| Morgan Stanley | 1,000 | $740 | 0.00% | +1,000 | New |
| Fortitude Family Office, LLC | 378 | $280 | 0.00% | +378 | New |
| Bank of America Corp | 107 | $79 | 0.00% | −69−39.2% | Reduced |
| Citigroup Inc | 1 | $1 | 0.00% | +1 | New |
| XTX Topco Ltd | 0 | $0 | 0.00% | −28,514−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −2,094−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −451−100.0% | Sold out |